Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms, Castration-Resistant × Omeprazole × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Neoplasms 1 Healthy Adult Participants 1 Breast Neoplasms 1

Interventions

Prednisone 5 enzalutamide 4 Docetaxel 4 Abiraterone Acetate 3 olaparib 1 niraparib 1 fludrocortisone acetate 1 darolutamide 1 cabazitaxel 1 abiraterone 1 Rosuvastatin Calcium 1 Pluvicto 1 Pioglitazone 1 Omeprazole 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04337580 2026-02-20

FASN

Wake Forest University Health Sciences

Phase 2 Recruiting

Neoplasms, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡